Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
NeyroblastGX
company
About
NeyroblastGX is a biotechnology company develops theranostic products to treat neurodegenerative and infectious diseases.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $255.99K
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2020
- Number Of Employee
- 1 - 10
- Operating Status
- Active
NeyroblastGX is a biotechnology company develops theranostic products to treat neurodegenerative and infectious diseases. The company was founded in 2020 and is headquartered in Murrieta, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$255.99K
NeyroblastGX has raised a total of
$255.99K
in funding over 2 rounds. Their latest funding was raised on
Mar 31, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 31, 2021 | Grant | $255.99K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
NeyroblastGX is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
